{"id":"W2965796930","doi":"10.1016/j.jaci.2019.07.013","title":"Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada)","funders":"Janssen Biotech; MedImmune; Glenmark Pharmaceuticals; Galderma; AstraZeneca; Asana Biosciences; Dermira; AbbVie; UCB; Celgene; Regeneron Pharmaceuticals; Novartis; Pfizer","keywords":"Syk; Atopic dermatitis; Janus kinase; Skin barrier; Inflammation; Filaggrin; Medicine; Janus; Dermatology; Immunology; Tyrosine kinase; Internal medicine; Cytokine; Receptor; Materials science; Nanotechnology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002213372,0.0001194055,0.0004698307,0.0001266918,0.00003769493,0.00001300858,0.000043995,0.0002319316,0.0001443103],"category_scores_gemma":[0.0002938717,0.00008760227,0.00006894043,0.00005578843,0.000273436,0.0003060904,0.00004318052,0.0003833994,0.000006340949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001425671,"about_ca_system_score_gemma":0.0000790668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009959526,"about_ca_topic_score_gemma":0.0000368043,"domain_scores_codex":[0.9986582,0.0002156793,0.0007049491,0.000142228,0.0001099076,0.0001689787],"domain_scores_gemma":[0.9990235,0.0003000642,0.0003225292,0.0001113024,0.0001441055,0.00009849128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001935015,0.0002329091,0.9839135,0.00004601642,0.0005596232,0.0001527585,0.00006641387,0.000001700229,0.0001581515,0.00007458005,0.0003513245,0.01250803],"study_design_scores_gemma":[0.008332382,0.001264395,0.9877361,0.0001869845,0.00008318909,0.0002380474,0.0001170832,0.00002603794,0.0002575587,0.0002998317,0.001367151,0.00009122716],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971074,0.001125269,0.000008204999,0.001137148,0.0002393639,0.000151304,0.000002281013,0.000005862958,0.0002231748],"genre_scores_gemma":[0.9982191,0.001068507,0.0001382684,0.0004462507,0.0000440962,0.000002116878,0.00001398016,0.000007896113,0.00005976553],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0124168,"threshold_uncertainty_score":0.3572317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007561517437909385,"score_gpt":0.2594861952114428,"score_spread":0.2519246777735334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}